Tooploox sp. z o.o.

Tooploox sp. z o. o. , based in Poland, specializes in custom AI solutions and software development services for innovative enterprises and startups across various sectors, enhancing operations and customer engagement through advanced technologies.

Tooploox sp. z o. o. provides tailored AI solutions and software development.

Founded in 2012, the company is headquartered in Wroclaw, Poland. The firm has engaged in one investment deal, with the most recent deal occurring on June 4, 2025. Specific details about the founder or any strategic pivots are not available. Tooploox specializes in providing custom AI solutions and software development services that cater to innovative enterprises and startups across various sectors.

Their core offerings include AI discovery, AI development, generative AI solutions, mobile development, web development, and product design. These services aim to enhance business operations by integrating advanced artificial intelligence technologies, improving customer engagement through personalized recommendations, and optimizing supply chain management with smart algorithms. Notable end use cases include AI-driven diagnostics in healthcare, predictive maintenance solutions in industrial automation, and precision farming technologies in agriculture. The company serves a diverse clientele, including e-commerce platforms, medical organizations, and manufacturing firms, with specific geographical markets encompassing Europe and North America.

Tooploox generates revenue through a combination of service agreements and project-based contracts, primarily operating on a B2B model. In the most recent year, 2021, the company reported a revenue of USD 10. 36 mn and an EBITDA of USD 932,126. 8.

Clients engage with the firm to develop tailored AI solutions, often structured as long-term partnerships or one-off projects. Pricing arrangements include fixed-rate contracts for specific developments, while ongoing support services may be billed on a subscription basis, ensuring continued access to updates and maintenance. The company’s flagship offerings, such as their AI-powered digital histopathology platform for cancer treatment and their generative AI solutions, contribute significantly to their revenue streams. In June 2025, Tooploox sp.

z o. o. was fully acquired by Solvd, LLC, a portfolio company of Siguler Guff, although financial terms were not disclosed. This acquisition enables Solvd, LLC to accelerate the integration of advanced AI technologies into enterprise systems, expand its business offerings, and scale internationally.

Plans for upcoming initiatives include launching new AI products designed to enhance data-driven decision-making by 2026, and expanding into the North American market by the same year.